Cosmetic cross-reference

Vanillin

CAS 121-33-5

Vanillin (CAS 121-33-5) is a pharmaceutical compound with 8 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
8
SOURCE DrugCentral / FAERS
Adverse signals
0
SOURCE IUPHAR / PharmGKB
PubMed IDs
2
SOURCE ChEMBL 36 B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Vanillin
CAS Number
121-33-5
UNII
CHI530446X
InChIKey
MWOOGOJBHIARFG-UHFFFAOYSA-N
ChEMBL ID
CHEMBL13883
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE ChEMBL 36 activities + assays 8 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- GI50 100000 nM 54 -
- IC50 45825.84 nM 15 -
- Potency 26252.925 nM 7 -
- IC50 18.685 ug.mL-1 6 -
- MIC 241120 nM 2 -
- MIC 600 ug.mL-1 2 -
- AC50 8912.5 nM 1 -
- Ki 29700 nM 1 -
SOURCE IUPHAR ligand-target interactions 4 interactions

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

TargetAction AffinityPubMed
TAS2R14
TAS2R14
Agonist 3.240000009536743 pEC50 34307435
TAS2R20
TAS2R20
Agonist 3.2799999713897705 pEC50 34307435
TAS2R39
TAS2R39
Agonist 3.059999942779541 pEC50 34307435
TRPV3
Trpv3
Activation - 16617338
SOURCE RxNorm drug names 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
VANILLIN 1368176 SU MTHSPL
vanillin 1368176 SU MTHSPL
vanillin 1368176 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Vanillin used for in pharmaceutical contexts?

Vanillin (CAS 121-33-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Vanillin?

No adverse-event association or SIDER side-effect rows are rendered for Vanillin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Vanillin also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Vanillin with EU status "restricted".

What clinical phase is Vanillin in?

No phase 1-4 clinical development badge is rendered for Vanillin because the matched compound identifier rows do not contain a max-phase value.